Laboratory Testing for Activated Protein C Resistance (APCR): An Update.
Favaloro EJ, Mohammed S, Vong R, Pasalic L.
Methods Mol Biol. 2023;2663:203-210. doi: 10.1007/978-1-0716-3175-1_11.
Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden.
Bahraini M, Fazeli A, Dorgalaleh A.
Semin Thromb Hemost. 2024 Nov;50(8):1067-1083. doi: 10.1055/s-0043-1770773. Epub 2023 Jul 10.
Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B.
Semin Thromb Hemost. 1999;25(3):273-89. doi: 10.1055/s-2007-994931.
Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay.
Amiral J, Vissac AM, Seghatchian J.
Transfus Apher Sci. 2017 Dec;56(6):906-913. doi: 10.1016/j.transci.2017.11.021. Epub 2017 Nov 14.
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.
Morimont L, Donis N, Bouvy C, Mullier F, Dogné JM, Douxfils J.
Semin Thromb Hemost. 2022 Sep;48(6):680-689. doi: 10.1055/s-0042-1758162. Epub 2022 Oct 12.
Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.
Van Cott EM, Soderberg BL, Laposata M.
Arch Pathol Lab Med. 2002 May;126(5):577-82. doi: 10.5858/2002-126-0577-APCRTF.
Activated protein C resistance and myocardial infarction.
Laffan MA.
Heart. 1998 Oct;80(4):319-21. doi: 10.1136/hrt.80.4.319.
Factor V Leiden and activated protein C resistance.
Segers O, Castoldi E.
Adv Clin Chem. 2009;49:121-57. doi: 10.1016/s0065-2423(09)49006-1.
Congenital and acquired activated protein C resistance.
Nicolaes GA, Dahlbäck B.
Semin Vasc Med. 2003 Feb;3(1):33-46. doi: 10.1055/s-2003-38331.
No resistance to activated protein C resistance-but choose wisely.
Selby R, Elbaz C.
J Thromb Haemost. 2019 Sep;17(9):1443-1445. doi: 10.1111/jth.14569.
